cancer
Conditions
Interventions
None listed
Sponsors
Department of Nutrition and Metabolism, Institute of Biomedical sciences Tokushima University Graduate School
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients with head and neck cancer, gynecological cancer, and lung cancer eligible for NST intervention who are hospitalized in our hospital 2) Patients 20 years of age or older 3) Patients who have undergone chemotherapy for cancer within 1 month prior to obtaining consent and have CTCAEv4.0-JCOG Grade 2 or higher nausea (marked weight loss, dehydration or decreased oral intake without malnutrition) 4) Patients scheduled to receive chemotherapy during hospitalization (5) Patients who are able to eat and drink orally. 6) Patients who are able to obtain written consent.
Exclusion criteria
Exclusion criteria: (1) Patients whose chemotherapy within 1 month prior to obtaining consent and whose planned chemotherapy is expected to change (2) Patients who are expected to change their chemotherapy antiemetic regimen within 1 month prior to obtaining consent and their scheduled chemotherapy antiemetic regimen. (3) Patients who are deemed inappropriate as research subjects by the Principal Investigator and the Principal Investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete response (CR) *CR is defined as nausea of 0 at NRS, no emetic events, and no emergency antiemetic use. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Nausea 2) Vomiting event 3) Urgent use of antiemetic drugs 4) Weight change 5) Compliance with intake (intervention group only) | — |
Countries
Japan
Contacts
Public ContactHiorhshi Sakaue
Tokushima University Graduate School Department of Nutrition and Metabolism, Institute of Biomedical sciences
Outcome results
None listed